Announcements

Jazz Pharmaceuticals Public Limited Company filed a current report on September 23, 2026, disclosing that its subsidiary Jazz Financing Lux S.à r.l. entered into Amendment No. 4 to its Credit Agreement, repricing and extending the maturity of its existing U.S. dollar term loan facility.

Theravance Biopharma, Inc. filed a current report on September 23, 2026, disclosing the completion of its merger with Zymeworks Inc., under which the Company became a wholly owned subsidiary of Zymeworks following the cancellation of all outstanding ordinary shares and equity awards.

Solaris Energy Infrastructure, Inc. filed a Form 8-K on September 23, 2026, disclosing that its subsidiary entered into a purchase agreement on September 22, 2026, to sell $1.25 billion aggregate principal amount of 7.000% Senior Notes due 2032 in a private placement.

Orange County Bancorp, Inc. filed a Form 8-K with the SEC on September 23, 2026, furnishing a slide presentation distributed to analysts and prospective investors in connection with the Stephens Bank Forum 2026.

Clarivate Plc filed a Form 8-K with the SEC on September 23, 2026, announcing that its wholly-owned subsidiary, Clarivate Science Holdings Corporation, had set the pricing terms for a previously announced cash tender offer for certain of its debt securities.

Jacobs Solutions Inc. filed an amended current report on September 23, 2026, disclosing the terms of a separation agreement entered into with former President Shannon Miller on September 22, 2026.

Teamshares Inc. filed a Form 8-K with the SEC on September 23, 2026, disclosing the closing of a Preferred Stock Purchase Agreement under which the company issued 225,000 shares of newly designated Series A Preferred Stock for aggregate proceeds of $222,750,000.